Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR)-Reference-Cited by-同舟云学术

Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR)

Published:2018-11-20 Issue:1 Volume:18 Page:
ISSN:1472-6882
Container-title:BMC Complementary and Alternative Medicine
language:en
Short-container-title:BMC Complement Altern Med

Author:

Tenorio-Jiménez Carmen,Martínez-Ramírez María José,Tercero-Lozano Mercedes,Arraiza-Irigoyen Carmen,Del Castillo-Codes Isabel,Olza Josune,Plaza-Díaz Julio,Fontana Luis,Migueles Jairo H.,Olivares Mónica,Gil Ángel,Gomez-Llorente Carolina^ORCID

Funder

Biosearch life

Publisher

Springer Science and Business Media LLC

Subject

Complementary and alternative medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12906-018-2371-x.pdf

Reference23 articles.

1. Kushner RF, Kahan S. Introduction: the state of obesity in 2017. Med Clin North Am. 2018;102(1):1–11.

2. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; world heart federation; international atherosclerosis society; and International Association for the Study of obesity. Circulation. 2009;120(16):1640–5.

3. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101(44):15718–23.